Alerus Financial’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.3M | Buy |
62,506
+5,391
| +9% | +$1.26M | 0.76% | 21 |
|
|
2025
Q4 | $11.8M | Buy |
57,115
+222
| +0.4% | +$43.9K | 0.58% | 25 |
|
|
2025
Q3 | $10.5M | Buy |
56,893
+2,659
| +5% | +$456K | 0.54% | 29 |
|
|
2025
Q2 | $8.28M | Sell |
54,234
-1,890
| -3% | -$291K | 0.6% | 36 |
|
|
2025
Q1 | $9.31M | Buy |
56,124
+1,939
| +4% | +$303K | 0.75% | 28 |
|
|
2024
Q4 | $7.84M | Buy |
54,185
+1,058
| +2% | +$164K | 0.6% | 39 |
|
|
2024
Q3 | $8.61M | Buy |
53,127
+24,296
| +84% | +$3.87M | 0.63% | 37 |
|
|
2024
Q2 | $4.21M | Buy |
28,831
+25,070
| +667% | +$3.73M | 0.32% | 70 |
|
|
2024
Q1 | $595K | Sell |
3,761
-121
| -3% | -$19.3K | 0.04% | 121 |
|
|
2023
Q4 | $608K | Sell |
3,882
-417
| -10% | -$63.9K | 0.05% | 105 |
|
|
2023
Q3 | $670K | Buy |
4,299
+71
| +2% | +$11.7K | 0.06% | 102 |
|
|
2023
Q2 | $700K | Sell |
4,228
-885
| -17% | -$143K | 0.06% | 107 |
|
|
2023
Q1 | $793K | Sell |
5,113
-601
| -11% | -$97K | 0.07% | 110 |
|
|
2022
Q4 | $1.01M | Sell |
5,714
-3,102
| -35% | -$536K | 0.09% | 107 |
|
|
2022
Q3 | $1.44M | Sell |
8,816
-78,506
| -90% | -$13.3M | 0.14% | 101 |
|
|
2022
Q2 | $15.5M | Buy |
87,322
+56,162
| +180% | +$10M | 1.43% | 15 |
|
|
2022
Q1 | $5.52M | Buy |
31,160
+2,781
| +10% | +$473K | 0.47% | 55 |
|
|
2021
Q4 | $4.86M | Sell |
28,379
-1,228
| -4% | -$201K | 0.4% | 65 |
|
|
2021
Q3 | $4.78M | Buy |
29,607
+896
| +3% | +$153K | 0.44% | 55 |
|
|
2021
Q2 | $4.73M | Sell |
28,711
-1,789
| -6% | -$296K | 0.48% | 52 |
|
|
2021
Q1 | $5.01M | Sell |
30,500
-40,565
| -57% | -$6.56M | 0.53% | 46 |
|
|
2020
Q4 | $11.2M | Sell |
71,065
-3,551
| -5% | -$524K | 1.14% | 16 |
|
|
2020
Q3 | $11.1M | Sell |
74,616
-6,588
| -8% | -$975K | 1.25% | 15 |
|
|
2020
Q2 | $11.4M | Buy |
81,204
+17,602
| +28% | +$2.57M | 1.34% | 14 |
|
|
2020
Q1 | $8.34M | Buy |
63,602
+155
| +0.2% | +$22K | 1.15% | 19 |
|
|
2019
Q4 | $9.26M | Buy |
63,447
+4,146
| +7% | +$562K | 1.05% | 20 |
|
|
2019
Q3 | $7.67M | Sell |
59,301
-32,202
| -35% | -$4.24M | 0.99% | 21 |
|
|
2019
Q2 | $12.7M | Buy |
91,503
+1,283
| +1% | +$178K | 1.72% | 10 |
|
|
2019
Q1 | $12.6M | Buy |
90,220
+2,126
| +2% | +$285K | 1.76% | 11 |
|
|
2018
Q4 | $11.4M | Buy |
88,094
+1,601
| +2% | +$223K | 1.74% | 12 |
|
|
2018
Q3 | $12M | Sell |
86,493
-5,249
| -6% | -$698K | 1.63% | 12 |
|
|
2018
Q2 | $11.1M | Buy |
91,742
+1,744
| +2% | +$218K | 1.58% | 12 |
|
|
2018
Q1 | $11.5M | Buy |
89,998
+6,617
| +8% | +$894K | 1.66% | 12 |
|
|
2017
Q4 | $11.7M | Sell |
83,381
-958
| -1% | -$133K | 1.65% | 13 |
|
|
2017
Q3 | $11M | Buy |
84,339
+1,124
| +1% | +$149K | 1.6% | 13 |
|
|
2017
Q2 | $11M | Buy |
83,215
+2,533
| +3% | +$323K | 1.63% | 13 |
|
|
2017
Q1 | $10M | Sell |
80,682
-682
| -0.8% | -$81.5K | 1.54% | 14 |
|
|
2016
Q4 | $9.37M | Sell |
81,364
-9,950
| -11% | -$1.15M | 1.51% | 14 |
|
|
2016
Q3 | $10.8M | Sell |
91,314
-7,122
| -7% | -$864K | 1.74% | 11 |
|
|
2016
Q2 | $11.9M | Buy |
+98,436
| New | +$11.2M | 2% | 9 |
|
Other funds holding JNJ
VCM
VPM
Alerus Financial's JNJ Position: Q1 2026 in Review
Alerus Financial increased its Johnson & Johnson (JNJ) stake by 9.4% in Q1 2026, buying an estimated $1.26M and bringing the position to 62,506 shares worth $15.3M. The position accounts for 0.76% of the portfolio, ranked #21.
Alerus Financial first reported a position in JNJ in Q2 2016 and has held it in 40 quarters since. The position peaked at $15.5M in Q2 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Alerus Financial held 62,506 shares of Johnson & Johnson worth $15.3M as of Q1 2026.
- Alerus Financial bought 5,391 Johnson & Johnson shares in Q1 2026, an estimated $1.26M.
- Johnson & Johnson made up 0.76% of Alerus Financial's portfolio in Q1 2026, its #21 holding.
- Alerus Financial first reported a position in Johnson & Johnson in Q2 2016 and has held it in 40 quarters since.
- Alerus Financial's Johnson & Johnson position peaked at $15.5M in Q2 2022.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.